GKOS — GLAUKOS CORP

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in GLAUKOS CORP (GKOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2025 Q2)
Avg. % of fund
0.17%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 263,889 +44,079 +20.1% 0.16% $21.5M $81.55
2025 Q2 INITIATED 219,810 — — 0.17% $22.7M $103.29
% of Fund (quarterly)    GKOS price (monthly, adj. close)

Other funds also holding GKOS

As of 2025 Q4 — sorted by position size

BRAIDWELL LP 3Y 3.33% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 3.02% PFM Health Sciences, LP 3Y 7Y 2.27% Rhenman & Partners Asset Management AB 3Y 7Y 2.22% Resolute Capital Asset Partners LLC 3Y 2.21% Integral Health Asset Management, LLC 3Y 1.82% Exome Asset Management LLC 1.7% Capricorn Fund Managers Ltd 3Y 1.63% Taylor Frigon Capital Management LLC 3Y 7Y 1.62% Sofinnova Investments, Inc. 3Y 7Y 1.4%
← Back to Freestone Grove Partners LP Holdings